Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,307 | 4,796 | -6,500 | -5,796 | -8,206 |
| Depreciation Amortization | 1,421 | 1,649 | 514 | 562 | 471 |
| Accounts receivable | 53 | 141 | -290 | 140 | 59 |
| Accounts payable and accrued liabilities | 31 | -156 | -150 | -175 | 3 |
| Other Working Capital | 163 | 112 | -796 | 271 | 704 |
| Other Operating Activity | 608 | -12,877 | -2,160 | -2,267 | -457 |
| Operating Cash Flow | $-6,031 | $-6,335 | $-9,382 | $-7,265 | $-7,426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -12 | -637 | -836 | -139 |
| Investing Cash Flow | $-24 | $-12 | $-637 | $-836 | $-139 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,770 | 3,441 | 1,086 | 6,776 | 21,430 |
| Financing Cash Flow | $5,770 | $3,441 | $1,086 | $6,776 | $21,430 |
| Exchange Rate Effect | 1 | -9 | -272 | -1,977 | 575 |
| Beginning Cash Position | 2,095 | 5,010 | 14,215 | 17,517 | 3,077 |
| End Cash Position | 1,811 | 2,095 | 5,010 | 14,215 | 17,517 |
| Net Cash Flow | $-284 | $-2,915 | $-9,205 | $-3,302 | $14,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,031 | -6,335 | -9,382 | -7,265 | -7,426 |
| Capital Expenditure | -24 | -12 | -637 | -836 | -139 |
| Free Cash Flow | -6,055 | -6,347 | -10,019 | -8,101 | -7,565 |